bluebird bio, Inc.
BLUEFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
84
Cost of Revenue
89
Gross Profit
-6
Gross Margin
-6.6%
Operating Income
-270
Operating Margin
-322.7%
Net Income
-241
Net Margin
-287.2%
EPS (Basic)
$-24.84
EPS (Diluted)
$-24.84
EBITDA
-157
EBITDA Margin
-187.1%
2023
12/31/2023
Revenue
29
Cost of Revenue
34
Gross Profit
-4
Gross Margin
-13.7%
Operating Income
-244
Operating Margin
-828.1%
Net Income
-212
Net Margin
-718.4%
EPS (Basic)
$-2.97
EPS (Diluted)
$-2.97
EBITDA
-167
EBITDA Margin
-566.7%
2022
12/31/2022
Revenue
4
Cost of Revenue
10
Gross Profit
-6
Gross Margin
-180.2%
Operating Income
-250
Operating Margin
-6955.4%
Net Income
-230
Net Margin
-6403.7%
EPS (Basic)
$-3.39
EPS (Diluted)
$-3.39
EBITDA
-216
EBITDA Margin
-5992.7%
2021
12/31/2021
Revenue
4
Cost of Revenue
39
Gross Profit
-35
Gross Margin
-961.1%
Operating Income
-591
Operating Margin
-16136.3%
Net Income
-819
Net Margin
-22375.2%
EPS (Basic)
$-8.16
EPS (Diluted)
$-8.16
EBITDA
-557
EBITDA Margin
-15208.2%
2020
12/31/2020
Revenue
251
Cost of Revenue
5
Gross Profit
245
Gross Margin
97.8%
Operating Income
-559
Operating Margin
-223.0%
Net Income
-619
Net Margin
-246.8%
EPS (Basic)
$-9.95
EPS (Diluted)
$-9.95
EBITDA
-554
EBITDA Margin
-220.8%